Ten additional states have joined the Certified Community Behavioral Health Clinic (CCBHC) Medicaid demonstration program, expanding access to comprehensive community-based behavioral health services that meet federal certification standards. The expansion occurs as pending legislation H.R. 1 threatens the demonstration's continued funding. CCBHCs provide integrated behavioral health and physical health screening, crisis services, and care coordination under enhanced Medicaid payment structures. The timing creates uncertainty for managed care organizations with CCBHC network arrangements and for states planning implementation.
Why it matters for managed care
MCOs in expansion states must prepare to contract with CCBHCs under specialized payment methodologies while monitoring federal funding risk that could disrupt network adequacy and behavioral health access.
Advocates for people with disabilities and older adults warn that federal support for home and community-based services (HCBS) may be weakening, 25 years after the Supreme Court's Olmstead decision established the right to receive long-term care at home rather than in institutions. The concern centers on potential policy changes that could reduce federal backing for community-based care options. This comes as Medicaid HCBS programs have grown substantially, with managed care organizations increasingly responsible for delivering and coordinating these services. Any reduction in federal support would directly affect MCO LTSS programs, reimbursement structures, and member access to community-based alternatives.
Why it matters for managed care
A rollback of federal HCBS support would force MCOs administering LTSS programs to navigate reduced funding, increased institutional placement pressure, and potential Olmstead compliance risks.
Latham & Watkins LLP published its third June 2026 digest tracking developments in drug pricing policy, including the Medicaid Drug Rebate Program, 340B Program, Medicare reforms, and state-level legislative activity. The digest compiles recent regulatory actions, guidance, and policy changes affecting pharmaceutical pricing and market access. The publication serves as an ongoing reference for tracking federal and state drug pricing policy developments. This tracker does not report a single new event but aggregates multiple developments from the period.
Why it matters for managed care
Medicaid managed care organizations with pharmacy benefits must monitor Medicaid Drug Rebate Program changes and 340B policy to manage formularies, capitation rate negotiations, and supplemental rebate agreements with manufacturers.
The Kaiser Family Foundation maintains an ongoing tracker of monthly Medicaid and CHIP enrollment figures across states. The tracker aggregates enrollment data reported by states and CMS, providing a centralized resource for monitoring program size and trends. It is updated as new monthly data becomes available from state and federal sources. The tracker serves as a reference tool for analyzing enrollment patterns following policy changes such as the end of continuous coverage provisions.
Why it matters for managed care
Enrollment trends directly affect capitation revenue, network capacity planning, and care management resource allocation for Medicaid managed care organizations.
CMS has finalized rule CMS-0053-F addressing prior authorization processes, but the regulation does not solve the underlying interoperability and standardization problems that have prevented automation. The rule requires electronic submission of prior authorization requests, moving away from fax-based workflows. However, it does not establish the data standardization or system integration needed for true automation. Medicaid managed care organizations will need to implement new electronic workflows while still handling manual review processes, creating a compliance obligation without the operational efficiency gains the industry expected.
Why it matters for managed care
MCOs must invest in electronic prior authorization infrastructure to comply with CMS-0053-F while maintaining manual review capacity, increasing administrative costs without delivering the automation-driven savings many organizations anticipated.
U.S. senators are advancing legislation to extend the $35 insulin cost cap beyond Medicare to cover private insurance and uninsured individuals. The Medicare cap, enacted under the Inflation Reduction Act, currently applies only to Medicare Part D beneficiaries. The proposed expansion would affect Medicaid managed care organizations that coordinate care for dual-eligible beneficiaries and states with Medicaid pharmacy carve-ins where commercial insulin pricing dynamics affect beneficiary access. No effective date or legislative timeline is specified in the report.
Why it matters for managed care
If enacted, MCOs managing pharmacy benefits would face new insulin pricing requirements that could affect formulary design, pharmacy network contracts, and coordination with commercial insurers for dual-eligible populations.
The Government Accountability Office found that HHS has not set near-term, measurable goals for the National Alzheimer's Project despite having long-term objectives like reducing Alzheimer's risk. Without these goals, HHS cannot effectively collect performance data, assess progress across the multi-agency initiative, or communicate results to stakeholders. GAO acknowledged the project has contributed to achievements including FDA-approved disease-modifying treatments and diagnostic advances. The report recommends HHS adopt key performance management practices to better track federal investments spread across multiple agencies through 2035, when the project's current authorization expires.
Why it matters for managed care
Medicaid managed care organizations covering long-term services and supports face growing Alzheimer's and dementia caseloads — the population is expected to double by 2050 — and federal performance gaps may limit coordination on risk reduction strategies, care protocols, and workforce planning that could reduce avoidable institutional care costs.
Senator Bernie Sanders released internal HHS emails indicating that HHS Secretary Robert F. Kennedy Jr. pressured the CDC to alter vaccine messaging and directed the CDC's vaccine advisory panel to restrict vaccine access. The emails document direct intervention in CDC communications and advisory processes. The release comes amid ongoing scrutiny of the administration's vaccine policy direction and its potential impact on public health programs.
Why it matters for managed care
Changes to federal vaccine policy and CDC messaging directly affect Medicaid MCO vaccine coverage requirements, VFC program administration, immunization performance metrics, and member outreach strategies.
The 988 Suicide and Crisis Lifeline is expanding specialized services for LGBTQ+ populations. The expansion addresses higher rates of crisis calls and mental health needs among LGBTQ+ individuals, particularly youth. For Medicaid managed care organizations, this development affects crisis service coordination and behavioral health network adequacy requirements, as many states require MCOs to integrate 988 into their crisis response systems. MCOs should assess whether their behavioral health networks can support LGBTQ-competent follow-up care for individuals diverted from emergency departments through 988.
Why it matters for managed care
Medicaid MCOs with behavioral health carve-ins must ensure network capacity for culturally competent crisis follow-up as 988 diverts LGBTQ+ members from higher-cost emergency settings.
Industry leaders at the PAYER Summit identified three payment trends reshaping home-based care delivery: value-based payment arrangements replacing fee-for-service, increased provider risk-sharing with managed care organizations, and stronger payment incentives for care coordination across post-acute settings. These shifts affect how MCOs structure home health and home-based primary care contracts. The trends reflect broader movement toward outcomes-based reimbursement in Medicaid managed long-term services and supports. Payer executives and providers agreed these payment changes will determine which home-based care organizations remain viable partners for health plans.
Why it matters for managed care
Medicaid MCOs contracting for home health and LTSS must adapt payment models to align with value-based care expectations and prepare providers for increased financial risk.
The National Academy for State Health Policy published revised model legislation allowing states to reference Medicare Maximum Fair Prices negotiated under the Inflation Reduction Act when setting prescription drug payment rates for state programs. The model act would apply to state-funded programs including Medicaid fee-for-service and potentially managed care pharmacy benefits. States can adapt the model to tie reimbursement rates to Medicare's negotiated prices for high-cost drugs, creating potential benchmark pricing constraints. The legislation offers states a mechanism to leverage federal negotiating power for prescription drug cost containment.
Why it matters for managed care
Medicaid MCOs with pharmacy risk may face state-mandated maximum reimbursement rates linked to Medicare negotiated prices, affecting pharmacy benefit management strategies and capitation rate adequacy for high-cost drugs.
A California Health Care Foundation report based on interviews with 39 undocumented Californians analyzes how recent Medi-Cal eligibility expansions interact with heightened immigration enforcement concerns. The qualitative research explores coverage enrollment decisions, trust barriers, and healthcare access patterns among undocumented individuals now eligible for Medi-Cal under California's eligibility expansions. The report documents how immigration policy uncertainty affects enrollment behavior and continuity of coverage even when individuals are legally eligible for benefits. Findings inform outreach strategies and enrollment retention efforts for managed care plans serving this population in California.
Why it matters for managed care
California Medicaid managed care organizations enrolling undocumented members under state eligibility expansions face distinct retention and engagement challenges driven by immigration enforcement fears that affect enrollment decisions and care utilization patterns.
Tennessee enacted legislation requiring state agencies to share data on public assistance program applicants and enrollees without qualified immigration status with federal immigration authorities. This requirement extends to the Children's Special Services program, which serves children with disabilities. The law affects eligibility and enrollment processes for state public assistance programs, including Medicaid-adjacent services. The policy creates operational challenges for managed care organizations and providers serving mixed-status families, potentially reducing program participation and complicating outreach and enrollment activities.
Why it matters for managed care
MCOs operating in Tennessee must prepare for enrollment declines and care coordination disruptions as families with mixed immigration status disengage from programs serving children with complex medical needs.
California's Department of Public Health approved temporary waivers for 23 of 35 psychiatric hospitals required to comply with new nurse-to-patient ratios that took effect June 1, 2026. The regulations mandate one nurse per six adult patients and one nurse per five youth patients in psychiatric units. The waivers allow non-compliant facilities to continue operating while they work toward meeting staffing requirements. This affects Medicaid managed care organizations with behavioral health carve-ins or delegated inpatient psychiatric contracts, as network adequacy and access standards depend on participating hospitals maintaining operational capacity.
Why it matters for managed care
Medicaid MCOs in California must monitor whether their contracted psychiatric hospitals received waivers, as staffing compliance directly affects inpatient psychiatric network adequacy and member access to covered behavioral health services.
Idaho's Behavioral Health Council is recommending that the state legislature direct opioid settlement funds toward rural communities in upcoming funding decisions. The council, which includes representatives from all three branches of state government, will present project proposals prioritizing rural areas. This recommendation comes as Idaho determines allocation of settlement funds received from opioid litigation. The focus on rural communities reflects ongoing challenges in accessing behavioral health services in non-urban areas of the state.
Why it matters for managed care
Medicaid managed care organizations with Idaho contracts may see increased rural behavioral health provider networks and treatment capacity if these recommendations influence state spending priorities.
The U.S. Department of Justice Antitrust Division filed civil complaints against hospital systems for using contract provisions that require health insurers to include them in nearly all commercial networks at preferred benefit tiers. These steering restrictions limit insurers' ability to design narrow network products. The OhioHealth settlement reflects DOJ's increased enforcement focus on payer contracting practices that constrain network design flexibility. While the cases involve commercial insurance, the enforcement trend signals heightened scrutiny of similar anti-steering and anti-tiering provisions that may appear in Medicaid managed care contracts.
Why it matters for managed care
Medicaid MCOs using similar anti-steering or most-favored-status clauses in provider contracts face increased antitrust enforcement risk and potential state regulatory review of network adequacy versus competitive contracting practices.